
Akeso Biopharma
康方生物
Akeso Biopharma
Biotech/Healthcare
Kangfang Biopharma (Akeso) is an innovative developer of new antibody drugs—a biopharmaceutical company focused on antibody and protein drug development, committed to discovering and developing innovative antibody medicines with independently held intellectual property rights. It is a subsidiary of…
Latest round: Post-IPO (2024)
Source: ChinaBulls — chinabulls.com
Last updated 2024-10-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.